VistaGen Therapeutics, Inc(NASDAQ:VTGN) 
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset n...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.26
H 2.38
L 2.15
C 2.35
V 232,007
10EMA 2.35
20EMA 2.35
60EMA 2.35
120EMA 2.35
250EMA 2.35